Literature DB >> 2428489

Cancer-associated alterations of blood group antigen expression in human colorectal polyps.

S H Itzkowitz, M Yuan, L D Ferrell, A Palekar, Y S Kim.   

Abstract

Human colorectal carcinoma tissues may exhibit several patterns of altered blood group substance (BGS) expression: reappearance of A, B, H, or Lewisb antigens in distal colon; deletion of BGS in the proximal colon with or without precursor substance accumulation; and incompatible BGS expression in proximal or distal colon. The present study evaluated these cancer-associated alterations in colorectal polyps with different malignant potential. With respect to ABH antigens, hyperplastic polyps (HPs), considered to have no malignant potential, did not exhibit incompatibility and only a few cases demonstrated BGS reappearance or deletion. Adenomatous polyps (APs) however, frequently reexpressed ABH antigens or expressed incompatible BG-A or B in 27% of polyps; one specimen demonstrated BG-B deletion. Precursor expression was not found in HPs but was frequently observed in APs. Reappearance of ABH in distal polyps was significantly correlated with increasing grade of dysplasia, but was not significantly correlated with polyp size or histological type. With respect to Lewis antigen expression, Lewisb reappearance occurred in almost every distal polyp, and Lewisa-Lewisb coexpression was also quite common. Lea deletion was frequently noted, especially in HP, but the significance of this finding is unclear. This study indicates that several antigenic alterations that occur in colorectal cancer tissues also appear in premalignant polyps, and often in early stages of the neoplastic process. The observation that incompatible expression of BG-A or B occurs only in AP and cancer tissues (as well as mucosa adjacent to cancer) but not in fetal colonic mucosa, adult normal colonic mucosa, or HP, suggests that this may be a cancer-specific phenomenon.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2428489

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  The expression of colorectal carcinoma-associated antigens in the normal colonic mucosa. An immunohistochemical analysis of regional distribution.

Authors:  B C Wolf; R R Salem; H F Sears; D A Horst; P T Lavin; M Herlyn; S H Itzkowitz; J Schlom; G D Steele
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

2.  Mucin associated Tn and sialosyl-Tn antigen expression in colorectal polyps.

Authors:  S H Itzkowitz; E J Bloom; T S Lau; Y S Kim
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

3.  Clinicopathologic evaluation of CDw75 antigen expression in colorectal adenocarcinomas.

Authors:  Gülsüm Ozlem Elpek; Tekinalp Gelen; Gülten Karpuzoglu; Tuncer Karpuzoglu; Nazif Hikmet Aksoy; Nuran Keles
Journal:  Pathol Oncol Res       Date:  2003-01-06       Impact factor: 3.201

4.  Comparative study on the expression of the blood group antigens Le a, Le b, Le x, Le y and the carbohydrate antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.

Authors:  J Schwenk; J Makovitzky
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

5.  Frequency and mechanism of Lewis antigen expression in human urinary bladder and colon carcinoma patients.

Authors:  N C Langkilde; H Wolf; P Meldgård; T F Orntoft
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

6.  The adenoma-carcinoma sequence in the colorectum--early appearance of a hierarchy of small intestinal mucin antigen (SIMA) epitopes and correlation with malignant potential.

Authors:  S J Pilbrow; P J Hertzog; A W Linnane
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

7.  The presence of CA19-9 in serum and saliva from Lewis blood-group negative cancer patients.

Authors:  S Yazawa; T Asao; H Izawa; Y Miyamoto; K L Matta
Journal:  Jpn J Cancer Res       Date:  1988-04

8.  Development and characterization of a novel anti-fucosylated antigen monoclonal antibody YB-2 and its usefulness in the immunohistochemical diagnosis of colorectal cancer.

Authors:  S Yazawa; S Akamatsu; T Tachikawa; H Naito; J Nakamura; T Asao; Y Nagamachi; T Nakajima; S Shin; D Chia
Journal:  Jpn J Cancer Res       Date:  1993-06

9.  Glycan-Based Near-infrared Fluorescent (NIRF) Imaging of Gastrointestinal Tumors: a Preclinical Proof-of-Concept In Vivo Study.

Authors:  Ruben D Houvast; Victor M Baart; Shadhvi S Bhairosingh; Robert A Cordfunke; Jia Xin Chua; Mireille Vankemmelbeke; Tina Parsons; Peter J K Kuppen; Lindy G Durrant; Alexander L Vahrmeijer; Cornelis F M Sier
Journal:  Mol Imaging Biol       Date:  2020-08-11       Impact factor: 3.488

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.